ebook Munafa Stock Market Course + Intraday & FNO calls  

       

Arbutus Biopharma (ABUS) Technical (Analysis) Reports Arbutus Biopharma ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com

Complete & easy to understand technical analysis of Arbutus Biopharma (ABUS)

Technical Analysis Report for USA stock ABUS Arbutus Biopharma. Dated: 12 Dec 2025 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in USA stock exchange

If you are looking for Tomorrow's Movement Predictions for USA stock ABUS Arbutus Biopharma then click here. or read Experts views on Arbutus Biopharma or Forecast & share price targets of Arbutus Biopharma

Arbutus Biopharma Opened at 4.68 and Closed at: 4.71, which is 0.85% of previous session's close. It moved within a range of 4.61 and 4.81
The session was a Bullish session with an average volume of 1570400, which is 7.43% of previous session's volumes.

    A Golden cross was found 2 days back on short term averages

    A Golden cross was found 1 days back on mid term averages

    Support for tomorrow is 4.66 and resistance for tomorrow is 4.86
    These support and resistance points are valid for the first 5-15 minutes charts

    Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.

    Support for tomorrow's hourly charts is 4.61, 4.51 resistance for tomorrow's hourly charts is 4.81, 4.91

    10 Day SMA for Arbutus Biopharma (ABUS) is 4.46 and stock is trading above these levels. This is a good sign for its short term trend

    20 Day SMA for Arbutus Biopharma (ABUS) is 4.41 and the stock is trading above these levels. This is a good sign for its mid term trend

    50 Day SMA for Arbutus Biopharma (ABUS) is 4.45 and the stock is trading above these levels. This is a good sign for its mid to long term trend

    100 Day SMA is 4.16 and the stock is trading above these levels. This is a good sign for its long term trend

    200 Day SMA Arbutus Biopharma is 3.73 and stock is trading above these levels. This is a good sign for its long term trend

    20 DMA of Arbutus Biopharma is at 4.41 and 200 DMA is at 3.73, while 50 DMA and 100 DMA are at 4.45 and 4.16 respectively

    Arbutus Biopharma (ABUS) moving average of 20 SMA is at 4.41 and 20 EMA is at 4.47

    Arbutus Biopharma (ABUS) moving average of 50 SMA is at 4.45 and 50 EMA is at 4.4

    Arbutus Biopharma (ABUS) moving average of 100 SMA is at 4.16 and 100 EMA is at 4.22

    Arbutus Biopharma (ABUS) moving average of 200 SMA is at 3.73 and 200 EMA is at 4.05

    Arbutus Biopharma has performed better than Takeda Pharmaceutical in short term. Holding Arbutus Biopharma could be a better choice for now!

    Arbutus Biopharma has performed better than Resmed Inc in short term. Holding Arbutus Biopharma could be a better choice for now!

    Arbutus Biopharma has performed better than 3m Company in short term. Holding Arbutus Biopharma could be a better choice for now!

    Arbutus Biopharma has performed better than Zai Lab in short term. Holding Arbutus Biopharma could be a better choice for now!

    Xencor Inc has performed better than Arbutus Biopharma in short term. You could have earned much better returns by investing in Xencor Inc, about 6.45% more returns!

    Vanda Pharmaceuticals has performed better than Arbutus Biopharma in short term. You could have earned much better returns by investing in Vanda Pharmaceuticals, about 39.02% more returns!

    Arbutus Biopharma has performed better than Trillium Therapeutics in short term. Holding Arbutus Biopharma could be a better choice for now!

    Trinity Biotech has performed better than Arbutus Biopharma in short term. You could have earned much better returns by investing in Trinity Biotech, about 17.39% more returns!

    Savara Inc has performed better than Arbutus Biopharma in short term. You could have earned much better returns by investing in Savara Inc, about 56.73% more returns!

    Arbutus Biopharma has performed better than Staar Surgical in short term. Holding Arbutus Biopharma could be a better choice for now!

    Arbutus Biopharma has performed better than Mersana Therapeutics in short term. Holding Arbutus Biopharma could be a better choice for now!

    Exact Sciences has performed better than Arbutus Biopharma in short term. You could have earned much better returns by investing in Exact Sciences, about 47.22% more returns!

    Arbutus Biopharma has performed better than Entera Bio in short term. Holding Arbutus Biopharma could be a better choice for now!

    Arbutus Biopharma has performed better than Dariohealth Corp in short term. Holding Arbutus Biopharma could be a better choice for now!

    Anavex Life has performed better than Arbutus Biopharma in short term. You could have earned much better returns by investing in Anavex Life, about 5.94% more returns!

    Arbutus Biopharma has performed better than Akari Therapeutics in short term. Holding Arbutus Biopharma could be a better choice for now!

    Arbutus Biopharma Technical analysis of indicators

    Price action analysis of Arbutus Biopharma (ABUS) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.

    ADX buy sell signal for Arbutus Biopharma stock for short term is BUY. Signal strength is Weak and stock is losing momentum.

    MACD generated a BUY signal for Arbutus Biopharma in short term and the buy signal is strong.

    MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.

    Arbutus Biopharma Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting stronger in this stock.

    Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up

    CCI has generated a buy signal for Arbutus Biopharma in short term and BUY signal is strong.

    RSI is generating a SELL signal in short term and selling is picking up momentum.

    MRSI is in positive zone. This is a BUY zone

    Although the stock is in the BUY zone, but buying might be slowing down

    Stock of Arbutus Biopharma is picking up selling momentum according to indicator.

    Volume based indicators are showing selling momentum.

    Volume Weighted Averaged Price (VWAP) for short term is 4.49 and Arbutus Biopharma ABUS stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.

    People seem to be coming out and selling the Arbutus Biopharma ABUS stock. Volume based technical analysis of Arbutus Biopharma ABUS stock is negative.

    Arbutus Biopharma Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.

    Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

    Tomorrow's Predictions

    You should also read Tomorrow's Movement Predictions for USA stock ABUS Arbutus Biopharma These predictions are based on various factors, are easy to understand, and upto 75% accurate!

    And ABUS Experts View which covers a lot of information including buying and selling signals

    ABUS future forecast & share price targets

    You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Arbutus Biopharma or View Candle Stick Charts here

    Chart Arbutus Biopharma (ABUS)  Technical (Analysis) Reports Arbutus Biopharma [

    Videos related to: Arbutus Biopharma (ABUS) Technical (Analysis) Reports Arbutus Biopharma ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com

    Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts

    Hindi Video Most Important Stock Market Video. No Success Without This Formula

    Arbutus Biopharma (ABUS)  Technical (Analysis) Reports Arbutus Biopharma [

     

    Back to top